| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |